Stocks making the biggest moves midday: Apple, Netflix, Biogen, Canopy Growth and more
Biogen is ready to roll on lecanemab production, CFO says
Biogen and Alcyone Therapeutics partner up for novel device for neurological ASO therapies
For women, business as unusual at Biogen - The Boston Globe
What clinical trials of the future might look like | Biogen
Biogen Plunges After Making Changes to Alzheimer's Drug Trial | BioSpace
Biogen targets 'lost to follow-up' patients in MS campaign - PMLiVE
Biogen: Strong Prospects With A Low Valuation (NASDAQ:BIIB) | Seeking Alpha
Biogen (BIIB) Loses Bid to Revive Patent on Tecfidera MS Drug - Bloomberg
Personal Care Wipes - Hangzhou Biogen Hygiene Co., Ltd. - page 1.
Biogen Announces Positive Phase 1 Results, Plan to License and Develop Ionis Pharmaceuticals' Investigational Therapy BIIB067 for Familial ALS - Muscular Dystrophy Association
Biogen's new Alzheimer's drug slows cognitive decline: study - Boston Business Journal
Biogen grapples with 'reckoning' over controversial Alzheimer's drug, reporters find | WBUR News
Biogen Alzheimer's Drug Coverage Threatens Minorities' Access
More Layoffs Hit Biogen as Drugmaker Cuts Multiple Sclerosis Team – NBC Boston
Biogen and Novartis release Q1 earnings reports: Mixed results and hope for 2023
Biogen's Qalsody Is a First for ALS Treatments - Bloomberg
Judge axes Biogen class action, rips shareholder lawyers for 'constant misrepresentation' | Reuters
Biogen Earnings Beat Expectations. All Eyes Are on the Alzheimer's Drug. | Barron's
CSRWire - Redefining What A Scientist Looks Like: Biogen Leaders Discuss the Importance of Women in STEM
Biogen begins cutting jobs following disastrous debut of its Alzheimer's drug - The Boston Globe
UPDATED: Biogen insists Eisai relationship 'solid' as questions remain over lecanemab commercialization | Fierce Biotech
Dr BABOR Biogen Cellular - The Goddess Beauty and ...
Biogen - Wikipedia
Biogen gears up Swiss manufacturing facility for potential aducanumab rollout | Fierce Pharma
Biogen's ALS Drug Tofersen Gets Partial Backing From FDA Panel - Bloomberg
Biogen boosts Aduhelm confirmatory trial amid fight for wider Medicare coverage | Fierce Pharma
